| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiovascular Diseases | 17 | 2025 | 749 | 1.730 |
Why?
|
| Biomedical Research | 5 | 2025 | 502 | 1.090 |
Why?
|
| Hypertension | 10 | 2025 | 835 | 0.860 |
Why?
|
| Mississippi | 24 | 2017 | 129 | 0.820 |
Why?
|
| Middle Aged | 59 | 2025 | 12222 | 0.750 |
Why?
|
| Blood Pressure | 11 | 2025 | 666 | 0.730 |
Why?
|
| Community-Based Participatory Research | 1 | 2025 | 352 | 0.720 |
Why?
|
| Aged | 50 | 2025 | 8214 | 0.710 |
Why?
|
| Pharmacists | 2 | 2021 | 61 | 0.670 |
Why?
|
| Humans | 84 | 2025 | 43102 | 0.660 |
Why?
|
| Public Health Administration | 1 | 2020 | 26 | 0.660 |
Why?
|
| Adult | 51 | 2025 | 13872 | 0.630 |
Why?
|
| Workload | 1 | 2020 | 25 | 0.630 |
Why?
|
| Pharmacy | 1 | 2020 | 34 | 0.620 |
Why?
|
| Obesity | 7 | 2020 | 1151 | 0.590 |
Why?
|
| Students, Pharmacy | 1 | 2020 | 58 | 0.570 |
Why?
|
| Female | 62 | 2025 | 24698 | 0.570 |
Why?
|
| Risk Factors | 25 | 2025 | 3994 | 0.550 |
Why?
|
| Male | 60 | 2025 | 23409 | 0.540 |
Why?
|
| United States | 14 | 2025 | 5205 | 0.530 |
Why?
|
| Tobacco Use Cessation | 1 | 2017 | 19 | 0.520 |
Why?
|
| Cholesterol, HDL | 4 | 2014 | 99 | 0.500 |
Why?
|
| Cohort Studies | 18 | 2025 | 1759 | 0.490 |
Why?
|
| Aged, 80 and over | 25 | 2021 | 2853 | 0.480 |
Why?
|
| Social Class | 6 | 2013 | 291 | 0.460 |
Why?
|
| Young Adult | 22 | 2021 | 5080 | 0.460 |
Why?
|
| Minority Groups | 4 | 2025 | 690 | 0.450 |
Why?
|
| Christianity | 1 | 2015 | 7 | 0.450 |
Why?
|
| Triglycerides | 4 | 2014 | 147 | 0.430 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2017 | 989 | 0.410 |
Why?
|
| Insulin Resistance | 4 | 2012 | 201 | 0.390 |
Why?
|
| Diabetes Mellitus | 5 | 2015 | 539 | 0.390 |
Why?
|
| Prevalence | 12 | 2017 | 1612 | 0.380 |
Why?
|
| Body Mass Index | 10 | 2018 | 925 | 0.360 |
Why?
|
| Lung | 2 | 2014 | 492 | 0.360 |
Why?
|
| Coronary Artery Bypass | 3 | 2017 | 47 | 0.350 |
Why?
|
| Weight Loss | 2 | 2023 | 137 | 0.350 |
Why?
|
| Hormone Replacement Therapy | 1 | 2011 | 49 | 0.340 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 40 | 0.340 |
Why?
|
| Menopause | 1 | 2011 | 64 | 0.340 |
Why?
|
| Magnesium | 2 | 2021 | 94 | 0.340 |
Why?
|
| Cross-Sectional Studies | 14 | 2025 | 3156 | 0.340 |
Why?
|
| Students | 1 | 2017 | 626 | 0.340 |
Why?
|
| Louisiana | 5 | 2025 | 50 | 0.320 |
Why?
|
| Quality of Life | 2 | 2018 | 616 | 0.310 |
Why?
|
| Coronary Disease | 1 | 2010 | 123 | 0.300 |
Why?
|
| Multivariate Analysis | 7 | 2020 | 638 | 0.300 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2015 | 45 | 0.290 |
Why?
|
| Life Style | 2 | 2023 | 334 | 0.290 |
Why?
|
| Health Promotion | 1 | 2015 | 704 | 0.280 |
Why?
|
| Coronary Artery Disease | 3 | 2016 | 163 | 0.280 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 166 | 0.280 |
Why?
|
| Environment | 1 | 2009 | 149 | 0.280 |
Why?
|
| Telemedicine | 2 | 2025 | 234 | 0.270 |
Why?
|
| National Institutes of Health (U.S.) | 2 | 2025 | 120 | 0.270 |
Why?
|
| Prospective Studies | 11 | 2019 | 1600 | 0.260 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2009 | 226 | 0.260 |
Why?
|
| Healthcare Disparities | 2 | 2025 | 590 | 0.260 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 5 | 2025 | 65 | 0.260 |
Why?
|
| Blood Glucose | 4 | 2014 | 389 | 0.250 |
Why?
|
| Health Status Disparities | 6 | 2025 | 719 | 0.250 |
Why?
|
| Cardiotonic Agents | 2 | 2017 | 40 | 0.240 |
Why?
|
| Sleep | 3 | 2021 | 185 | 0.230 |
Why?
|
| Respiratory Tract Diseases | 1 | 2025 | 31 | 0.230 |
Why?
|
| Erythrocyte Indices | 1 | 2025 | 14 | 0.220 |
Why?
|
| Atrial Fibrillation | 2 | 2017 | 122 | 0.220 |
Why?
|
| Narcotic Antagonists | 1 | 2025 | 78 | 0.220 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2025 | 54 | 0.220 |
Why?
|
| Buprenorphine | 1 | 2025 | 51 | 0.220 |
Why?
|
| Secondary Prevention | 1 | 2024 | 48 | 0.210 |
Why?
|
| Stress, Psychological | 4 | 2016 | 661 | 0.210 |
Why?
|
| Regression Analysis | 4 | 2020 | 490 | 0.210 |
Why?
|
| Erythrocytes | 1 | 2025 | 126 | 0.210 |
Why?
|
| Recurrence | 1 | 2024 | 152 | 0.210 |
Why?
|
| Retrospective Studies | 8 | 2021 | 2544 | 0.200 |
Why?
|
| Research Design | 5 | 2018 | 385 | 0.200 |
Why?
|
| Stroke | 2 | 2024 | 340 | 0.200 |
Why?
|
| Echocardiography | 4 | 2015 | 167 | 0.200 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 760 | 0.200 |
Why?
|
| Vaccination | 1 | 2025 | 355 | 0.190 |
Why?
|
| Exercise | 3 | 2020 | 692 | 0.190 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 278 | 0.190 |
Why?
|
| Minority Health | 2 | 2022 | 95 | 0.190 |
Why?
|
| Hospitalization | 2 | 2011 | 485 | 0.180 |
Why?
|
| Population Surveillance | 4 | 2014 | 246 | 0.180 |
Why?
|
| Opioid-Related Disorders | 1 | 2025 | 195 | 0.180 |
Why?
|
| Longitudinal Studies | 9 | 2018 | 1063 | 0.180 |
Why?
|
| Cooperative Behavior | 2 | 2025 | 269 | 0.170 |
Why?
|
| Adolescent | 8 | 2021 | 6081 | 0.170 |
Why?
|
| Program Development | 2 | 2015 | 240 | 0.170 |
Why?
|
| Public Health | 1 | 2025 | 424 | 0.170 |
Why?
|
| Pharmaceutical Services | 1 | 2021 | 25 | 0.170 |
Why?
|
| Intra-Abdominal Fat | 2 | 2012 | 46 | 0.170 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2025 | 497 | 0.160 |
Why?
|
| Genetic Loci | 2 | 2010 | 104 | 0.160 |
Why?
|
| Insulin | 2 | 2012 | 258 | 0.160 |
Why?
|
| Breast Neoplasms | 1 | 2011 | 1723 | 0.150 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2014 | 193 | 0.150 |
Why?
|
| Biostatistics | 1 | 2018 | 10 | 0.150 |
Why?
|
| Behavioral Research | 1 | 2019 | 41 | 0.140 |
Why?
|
| Calcium | 1 | 2021 | 491 | 0.140 |
Why?
|
| Primary Health Care | 2 | 2020 | 380 | 0.140 |
Why?
|
| C-Reactive Protein | 2 | 2010 | 167 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2018 | 11 | 0.140 |
Why?
|
| Urban Population | 2 | 2010 | 374 | 0.140 |
Why?
|
| Health Services Research | 1 | 2018 | 161 | 0.140 |
Why?
|
| Ghana | 4 | 2025 | 36 | 0.130 |
Why?
|
| Patient Education as Topic | 2 | 2020 | 235 | 0.130 |
Why?
|
| Research Personnel | 3 | 2025 | 206 | 0.130 |
Why?
|
| Prenatal Care | 1 | 2018 | 93 | 0.130 |
Why?
|
| Incidence | 4 | 2015 | 1078 | 0.130 |
Why?
|
| Circadian Rhythm | 3 | 2016 | 236 | 0.130 |
Why?
|
| Diastole | 2 | 2021 | 47 | 0.120 |
Why?
|
| Sex Factors | 4 | 2012 | 1028 | 0.120 |
Why?
|
| Universities | 2 | 2017 | 559 | 0.120 |
Why?
|
| Obesity, Abdominal | 2 | 2014 | 29 | 0.120 |
Why?
|
| Risk | 4 | 2018 | 287 | 0.120 |
Why?
|
| Postoperative Care | 1 | 2015 | 20 | 0.120 |
Why?
|
| Cholesterol | 1 | 2017 | 232 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2025 | 863 | 0.110 |
Why?
|
| Organizational Objectives | 1 | 2015 | 33 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2017 | 263 | 0.110 |
Why?
|
| Rural Population | 3 | 2018 | 373 | 0.110 |
Why?
|
| Nicotine | 1 | 2017 | 302 | 0.110 |
Why?
|
| Insecticide-Treated Bednets | 1 | 2014 | 8 | 0.110 |
Why?
|
| Infant Care | 1 | 2014 | 6 | 0.110 |
Why?
|
| Personnel, Hospital | 1 | 2014 | 11 | 0.110 |
Why?
|
| Health Surveys | 3 | 2014 | 405 | 0.100 |
Why?
|
| Prognosis | 3 | 2015 | 861 | 0.100 |
Why?
|
| Mosquito Control | 1 | 2014 | 15 | 0.100 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2014 | 22 | 0.100 |
Why?
|
| Hypokalemia | 1 | 2013 | 11 | 0.100 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 50 | 0.100 |
Why?
|
| Heart Conduction System | 1 | 2013 | 15 | 0.100 |
Why?
|
| Electrocardiography | 2 | 2013 | 185 | 0.100 |
Why?
|
| Case-Control Studies | 4 | 2021 | 1285 | 0.100 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 55 | 0.100 |
Why?
|
| Infant Mortality | 1 | 2014 | 65 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2013 | 31 | 0.100 |
Why?
|
| Proteinuria | 1 | 2013 | 56 | 0.100 |
Why?
|
| Chromosome Mapping | 2 | 2010 | 199 | 0.100 |
Why?
|
| Malaria | 1 | 2014 | 90 | 0.100 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2011 | 96 | 0.100 |
Why?
|
| Refusal to Participate | 1 | 2012 | 3 | 0.090 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2012 | 1 | 0.090 |
Why?
|
| Parenting | 1 | 2013 | 137 | 0.090 |
Why?
|
| Allostasis | 1 | 2012 | 25 | 0.090 |
Why?
|
| Nigeria | 2 | 2025 | 92 | 0.090 |
Why?
|
| Persuasive Communication | 1 | 2011 | 9 | 0.090 |
Why?
|
| Hyperglycemia | 1 | 2012 | 61 | 0.090 |
Why?
|
| Public Health Practice | 1 | 2011 | 39 | 0.090 |
Why?
|
| Spirometry | 1 | 2011 | 40 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2011 | 75 | 0.090 |
Why?
|
| Adiponectin | 1 | 2011 | 59 | 0.090 |
Why?
|
| Prejudice | 1 | 2012 | 116 | 0.090 |
Why?
|
| Income | 1 | 2012 | 160 | 0.090 |
Why?
|
| Age Factors | 2 | 2012 | 1154 | 0.080 |
Why?
|
| Disease Progression | 2 | 2015 | 667 | 0.080 |
Why?
|
| Models, Biological | 1 | 2014 | 712 | 0.080 |
Why?
|
| Sodium Channels | 1 | 2011 | 65 | 0.080 |
Why?
|
| Motivation | 1 | 2015 | 513 | 0.080 |
Why?
|
| Educational Status | 1 | 2012 | 339 | 0.080 |
Why?
|
| Health Education | 1 | 2013 | 363 | 0.080 |
Why?
|
| Pericardium | 1 | 2010 | 15 | 0.080 |
Why?
|
| Health Status Indicators | 2 | 2007 | 90 | 0.080 |
Why?
|
| Epidemiologic Methods | 1 | 2010 | 56 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2011 | 233 | 0.080 |
Why?
|
| Geographic Information Systems | 1 | 2010 | 47 | 0.080 |
Why?
|
| Echocardiography, Doppler | 1 | 2009 | 41 | 0.080 |
Why?
|
| Long QT Syndrome | 1 | 2009 | 15 | 0.080 |
Why?
|
| Public Policy | 1 | 2009 | 36 | 0.070 |
Why?
|
| Professional Competence | 1 | 2009 | 42 | 0.070 |
Why?
|
| Health Services | 1 | 2009 | 61 | 0.070 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 148 | 0.070 |
Why?
|
| Adaptation, Psychological | 2 | 2013 | 420 | 0.070 |
Why?
|
| Cholesterol, LDL | 1 | 2009 | 73 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2009 | 48 | 0.070 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 114 | 0.070 |
Why?
|
| Attitude | 1 | 2009 | 108 | 0.070 |
Why?
|
| Phenotype | 2 | 2009 | 780 | 0.070 |
Why?
|
| Workplace | 1 | 2009 | 92 | 0.070 |
Why?
|
| Lipids | 1 | 2010 | 256 | 0.070 |
Why?
|
| Needs Assessment | 1 | 2010 | 178 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 1067 | 0.070 |
Why?
|
| Genome, Human | 1 | 2009 | 144 | 0.070 |
Why?
|
| Residence Characteristics | 3 | 2005 | 363 | 0.070 |
Why?
|
| Proteins | 1 | 2010 | 382 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 734 | 0.070 |
Why?
|
| Schools | 1 | 2009 | 283 | 0.060 |
Why?
|
| Health Behavior | 1 | 2011 | 575 | 0.060 |
Why?
|
| Systole | 2 | 2021 | 67 | 0.060 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 86 | 0.060 |
Why?
|
| Smoking | 1 | 2014 | 1024 | 0.060 |
Why?
|
| Health Literacy | 2 | 2020 | 130 | 0.060 |
Why?
|
| Waist Circumference | 3 | 2012 | 90 | 0.060 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2012 | 863 | 0.060 |
Why?
|
| Caribbean Region | 1 | 2025 | 79 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 43 | 0.050 |
Why?
|
| Laboratories | 1 | 2004 | 40 | 0.050 |
Why?
|
| Logistic Models | 3 | 2013 | 1009 | 0.050 |
Why?
|
| Disability Evaluation | 1 | 2024 | 73 | 0.050 |
Why?
|
| Predictive Value of Tests | 1 | 2025 | 440 | 0.050 |
Why?
|
| Feedback | 1 | 2023 | 56 | 0.050 |
Why?
|
| Genome-Wide Association Study | 3 | 2010 | 423 | 0.050 |
Why?
|
| Dementia | 1 | 2024 | 160 | 0.050 |
Why?
|
| Patient Selection | 1 | 2005 | 205 | 0.050 |
Why?
|
| Research | 1 | 2004 | 181 | 0.050 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 1234 | 0.050 |
Why?
|
| Depression | 2 | 2024 | 863 | 0.050 |
Why?
|
| Infant, Newborn | 3 | 2014 | 972 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2012 | 162 | 0.040 |
Why?
|
| Pregnancy | 3 | 2018 | 1772 | 0.040 |
Why?
|
| Actigraphy | 1 | 2021 | 17 | 0.040 |
Why?
|
| Focus Groups | 1 | 2023 | 423 | 0.040 |
Why?
|
| Sex Distribution | 2 | 2013 | 224 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2020 | 23 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 117 | 0.040 |
Why?
|
| Time Factors | 2 | 2015 | 1857 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2023 | 574 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 184 | 0.040 |
Why?
|
| Georgia | 1 | 2019 | 192 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2019 | 89 | 0.040 |
Why?
|
| Computers, Handheld | 1 | 2018 | 6 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2018 | 15 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 61 | 0.030 |
Why?
|
| Linear Models | 2 | 2009 | 317 | 0.030 |
Why?
|
| Rural Health Services | 1 | 2018 | 48 | 0.030 |
Why?
|
| Cultural Diversity | 1 | 2019 | 193 | 0.030 |
Why?
|
| Perioperative Care | 1 | 2017 | 11 | 0.030 |
Why?
|
| Genotype | 2 | 2011 | 800 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 437 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2011 | 452 | 0.030 |
Why?
|
| Patient Participation | 1 | 2018 | 94 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2018 | 138 | 0.030 |
Why?
|
| Brain | 1 | 2024 | 1472 | 0.030 |
Why?
|
| Self Care | 1 | 2018 | 175 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 375 | 0.030 |
Why?
|
| Internet | 1 | 2018 | 236 | 0.030 |
Why?
|
| Likelihood Functions | 1 | 2016 | 62 | 0.030 |
Why?
|
| Comorbidity | 2 | 2011 | 737 | 0.030 |
Why?
|
| Child | 2 | 2014 | 3443 | 0.030 |
Why?
|
| Forecasting | 1 | 2016 | 136 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 310 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2016 | 232 | 0.030 |
Why?
|
| Poverty | 1 | 2018 | 400 | 0.030 |
Why?
|
| Hospitals, District | 1 | 2014 | 2 | 0.030 |
Why?
|
| World Health Organization | 1 | 2014 | 36 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2013 | 34 | 0.030 |
Why?
|
| Maryland | 1 | 2014 | 66 | 0.030 |
Why?
|
| International Cooperation | 1 | 2014 | 52 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 61 | 0.030 |
Why?
|
| Inservice Training | 1 | 2014 | 33 | 0.030 |
Why?
|
| Insecticides | 1 | 2014 | 54 | 0.030 |
Why?
|
| Psychological Theory | 1 | 2013 | 26 | 0.030 |
Why?
|
| Lung Diseases | 1 | 2014 | 63 | 0.020 |
Why?
|
| Cause of Death | 1 | 2014 | 186 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 179 | 0.020 |
Why?
|
| Child Development | 1 | 2013 | 99 | 0.020 |
Why?
|
| Social Support | 1 | 2016 | 445 | 0.020 |
Why?
|
| Mentors | 1 | 2014 | 145 | 0.020 |
Why?
|
| Alleles | 1 | 2013 | 352 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 1081 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2014 | 359 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 88 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 103 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 206 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 71 | 0.020 |
Why?
|
| Overweight | 1 | 2014 | 249 | 0.020 |
Why?
|
| Poisson Distribution | 1 | 2011 | 44 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 54 | 0.020 |
Why?
|
| Osteopetrosis | 1 | 1991 | 4 | 0.020 |
Why?
|
| Body Composition | 1 | 2012 | 159 | 0.020 |
Why?
|
| Curriculum | 1 | 2013 | 318 | 0.020 |
Why?
|
| Awareness | 1 | 2011 | 73 | 0.020 |
Why?
|
| Tibia | 1 | 1991 | 26 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 760 | 0.020 |
Why?
|
| Fasting | 1 | 2011 | 56 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2011 | 42 | 0.020 |
Why?
|
| Lipid Metabolism Disorders | 1 | 2010 | 5 | 0.020 |
Why?
|
| Pregnancy, Multiple | 1 | 1990 | 6 | 0.020 |
Why?
|
| Twins | 1 | 1990 | 19 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2012 | 587 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 1175 | 0.020 |
Why?
|
| Trust | 1 | 2012 | 167 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2010 | 32 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 2010 | 34 | 0.020 |
Why?
|
| Fetal Blood | 1 | 1990 | 48 | 0.020 |
Why?
|
| Censuses | 1 | 2010 | 28 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 1990 | 86 | 0.020 |
Why?
|
| Calcinosis | 1 | 2010 | 62 | 0.020 |
Why?
|
| Genetics, Population | 1 | 2010 | 121 | 0.020 |
Why?
|
| Heart Rate | 1 | 2011 | 266 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 2009 | 26 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 1546 | 0.020 |
Why?
|
| Albuminuria | 1 | 2010 | 78 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2010 | 147 | 0.020 |
Why?
|
| Demography | 1 | 2010 | 195 | 0.020 |
Why?
|
| Markov Chains | 1 | 2009 | 43 | 0.020 |
Why?
|
| Oxygen | 1 | 1990 | 218 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2010 | 245 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 263 | 0.020 |
Why?
|
| Health Status | 1 | 2012 | 442 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2010 | 341 | 0.020 |
Why?
|
| Software | 1 | 2010 | 236 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2010 | 169 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2009 | 430 | 0.010 |
Why?
|
| Heart Failure | 1 | 2009 | 302 | 0.010 |
Why?
|
| Psychometrics | 1 | 2007 | 358 | 0.010 |
Why?
|
| Research Subjects | 1 | 2005 | 35 | 0.010 |
Why?
|
| HIV Infections | 1 | 2012 | 2586 | 0.010 |
Why?
|
| Bone Resorption | 1 | 1991 | 22 | 0.010 |
Why?
|
| Osteoclasts | 1 | 1991 | 28 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1991 | 83 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1991 | 159 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 210 | 0.010 |
Why?
|
| Apgar Score | 1 | 1990 | 5 | 0.010 |
Why?
|
| Labor Presentation | 1 | 1990 | 3 | 0.010 |
Why?
|
| Bicarbonates | 1 | 1990 | 13 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1990 | 63 | 0.000 |
Why?
|
| Analysis of Variance | 1 | 1991 | 575 | 0.000 |
Why?
|
| Mice | 1 | 1991 | 6644 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 16992 | 0.000 |
Why?
|